| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/21/2004 | EP1438047A2 Compounds for reducing excessive intake of food |
| 07/21/2004 | EP1438044A1 Bis-heteroaryl alkanes as therapeutic agents |
| 07/21/2004 | EP1438043A2 Method of reducing type 2 diabetes in high risk patients |
| 07/21/2004 | EP1438039A2 Product comprising mikanolide, dihydromikanolide or an analogue thereof combined with another anti-cancer agent for therapeutic use in cancer treatment |
| 07/21/2004 | EP1438038A1 Method and composition for preventing or reducing the symptoms of insulin resistance syndrome |
| 07/21/2004 | EP1438037A1 Methods for treating dry eye by a combination of an antiinflammatory steroid and a muc-1 secretagogue |
| 07/21/2004 | EP1438035A2 Pharmaceutical compositions for the treatment of urinary disorders |
| 07/21/2004 | EP1438027A1 Methods of treatment using a gastric retained losartan dosage |
| 07/21/2004 | EP1438020A2 Topical compositions and methods for treating pain |
| 07/21/2004 | EP1438019A1 Kit for the preparation of a pharmaceutical composition |
| 07/21/2004 | EP1437961A2 Methods of suppressing microglial activation |
| 07/21/2004 | EP1357977B1 Chromium containing compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity and reduction of hyperglycemia and hypercholesteremia |
| 07/21/2004 | EP1254251A4 Neurosteroids as markers for alzheimer's disease |
| 07/21/2004 | EP1200110A4 In vivo induction for enhanced function of isolated hepatocytes |
| 07/21/2004 | EP1067941B1 Antitumor composition containing a synergistic combination of an anthracycline derivative with a camptothecin derivate |
| 07/21/2004 | EP0932402B1 Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia |
| 07/21/2004 | EP0643775B1 Quinone derivatives for enhancing cellular bioenergy |
| 07/21/2004 | CN1514833A Novel tyrosine kinase inhibitors |
| 07/21/2004 | CN1514737A Method of treatment of vascular regeneration |
| 07/21/2004 | CN1514727A Favorable modulation of health-related quality of life and health-related quality-adjusted time-to progression of disease in patients with prostate cancer |
| 07/21/2004 | CN1514726A Pharmaceutical compositions |
| 07/21/2004 | CN1514725A Pharmaceutical composition comprising lipase inhibitor and sucrose fatty acid ester |
| 07/21/2004 | CN1514720A Self emulsifying lipid matrix (SELM) |
| 07/21/2004 | CN1513564A Germ interstitial antisenility technology |
| 07/21/2004 | CN1513557A Compound cortex steroid medicinal composition |
| 07/21/2004 | CN1513556A Recombination human Mucl-MBP fusion protein antitumour vaccine and production technology |
| 07/21/2004 | CN1158299C Substituted 4-benzylaminoquinoline, method for producing the same, medicaments containing these compounds and their use |
| 07/21/2004 | CN1158081C Medicine composition containing active vitamin D compound and its use |
| 07/21/2004 | CN1158073C Application of protein kinase C inhibitor in preparing medicine |
| 07/21/2004 | CN1158069C Antibacterial oil-in-water emulsions |
| 07/21/2004 | CN1158068C Polyol/oil suspensions for the sustained release of proteins |
| 07/20/2004 | USRE38558 Polyoxypropylene/polyoxyethylene copolymers with improved biological activity |
| 07/20/2004 | US6764826 Detcting modulators of c-reactive proteins; obtain c-reactive protein, incubate with modulator, monitor binding between reactive protein and modulator |
| 07/20/2004 | US6764693 Free radical quenching composition and a method to increase intracellular and/or extracellular antioxidants |
| 07/20/2004 | US6764692 Administering naturally chelated trace mineral for healthy skin, hair and hoof tissue |
| 07/20/2004 | US6764678 Local anesthetic methods and kits |
| 07/20/2004 | CA2231194C Pharmaceutical formulation |
| 07/17/2004 | CA2416799A1 Pharmaceutical compositions and methods for treating multidrug resistant cancer |
| 07/15/2004 | WO2004058790A1 Nitrogen-containing heterocycic derivatives, medicinal compositions containing the same and medicinal use thereof |
| 07/15/2004 | WO2004058354A1 Compositions of cyclooxygenase-2 selective inhibitors and selective serotonin reuptake inhibitors for the treatment or prevention of a vaso-occlusive event |
| 07/15/2004 | WO2004058353A2 Therapeutic use of selective noradrenaline reuptake inhibitors |
| 07/15/2004 | WO2004058302A1 Method of using a cox-2 inhibitor and a topoisomerase ii inhibitor as a combination therapy in the treatment of neoplasia |
| 07/15/2004 | WO2004058301A1 Composition for improving swallowing reflex failure |
| 07/15/2004 | WO2004058289A1 Ophthalmic formulation for the prevention and treatment of ocular conditions |
| 07/15/2004 | WO2004058286A1 Administration of capsaicinoids |
| 07/15/2004 | WO2004058281A1 Cholesterol-reducing agent containing an n-3 fatty acid |
| 07/15/2004 | WO2004058272A1 Steroid compositions for intraocular use |
| 07/15/2004 | WO2004058269A1 Use of gnrh agonists to support the luteal phase during infertility treatment |
| 07/15/2004 | WO2004058258A1 Therapeutic formulations for the treatment of beta-amyloid related diseases |
| 07/15/2004 | WO2004058239A1 Therapeutic formulations for the treatment of beta-amyloid related diseases |
| 07/15/2004 | WO2004058171A2 Antibodies against gpr64 and uses thereof |
| 07/15/2004 | WO2004058163A2 Pharmaceutical compositions and method of treating parkinson's disease |
| 07/15/2004 | WO2004045536A3 Method and compositions for temporarily incapaciting subjets |
| 07/15/2004 | WO2004045505A3 Extract of stephaniae sinica diels and methods of using the same |
| 07/15/2004 | WO2004043341A3 Treatment for hemorrhagic shock |
| 07/15/2004 | WO2004041169A3 Modulation of cell fates and activities by phthalazine diones |
| 07/15/2004 | WO2004041158A3 Rifalazil compositions and therapeutic regimens |
| 07/15/2004 | WO2004028453A3 Methods for preventing and treating obesity in patients with mc4 receptor mutations |
| 07/15/2004 | WO2004026242A3 Substituted ketophosphonate inhibitors of tumor cell proliferation |
| 07/15/2004 | WO2004024879A3 RORs AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 07/15/2004 | WO2004024130A3 TREATMENT OF CNS DISORDERS WITH trans 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-N-METHYL-1-NAPTHALENAMINE |
| 07/15/2004 | WO2004016100A3 Nutritional supplement for adolescents |
| 07/15/2004 | WO2004015089A3 Polyionic organic acid formulations |
| 07/15/2004 | WO2004002535A8 Use of an npy y2 receptor antagonist for treating disorders related to angiogenesis |
| 07/15/2004 | WO2003092613A3 Catechin multimers as therapeutic drug delivery agents |
| 07/15/2004 | WO2003082197A3 Immunosuppressant compounds, methods and uses related thereto |
| 07/15/2004 | WO2003078579A3 Compositions and methods for treating emphysema |
| 07/15/2004 | WO2003075852A3 Antibiotic composition |
| 07/15/2004 | WO2003075836A3 Cathepsin cysteine protease inhibitors |
| 07/15/2004 | WO2003070965A9 The eaat2 promoter and uses thereof |
| 07/15/2004 | WO2003070883A3 Methods and compositions for treating aids and hiv-related disorders using 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045 molecules. |
| 07/15/2004 | WO2003063893B1 Fgfr agonists |
| 07/15/2004 | WO2003047513A3 Method for treating ocular hypertension |
| 07/15/2004 | WO2003044162A3 Genes encoding g-protein coupled receptors and methods of use therefor |
| 07/15/2004 | WO2002081636A3 Protein modification and maintenance molecules |
| 07/15/2004 | US20040138454 Drugs for treating pain formed by arylation |
| 07/15/2004 | US20040138416 Comprises membrane protein for use in diagnosis prevention and treatment of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune, inflammatory, metabolic and viral disorders |
| 07/15/2004 | US20040138415 Helicobacter proteins, nucleic acids and uses thereof |
| 07/15/2004 | US20040138414 Secreted proteins |
| 07/15/2004 | US20040138311 medicament enables disturbances of thiol-disulfide status or those that occur, for example, in diabetes melltus to be treated simultaneously, separately or in a temporally graduated manner |
| 07/15/2004 | US20040138306 Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure |
| 07/15/2004 | US20040138305 Alpha2delta ligands for the treatment of fibromyalgia and other disorders |
| 07/15/2004 | US20040138303 Administering 7-oxo-dehydroepiandrosterone (DHEA) or prodrug incapable of in vivo conversion to testosterone |
| 07/15/2004 | US20040138296 Amyloid immunization and Cox-2 inhibitors for the treatment of alzheimer's disease |
| 07/15/2004 | US20040138291 Hypotensive therapy; administering angiotensin converting enzyme ( ACE) inhibitor such as enalapril, and dopaminergic agonist apomorphine or salt or ester thereof |
| 07/15/2004 | US20040138285 Low molecular weight compound and MEK1 inhibitor; bone disorders; osteoarthritis, arthritis |
| 07/15/2004 | US20040138257 Chemical derivatives and their application as antitelomerase agent |
| 07/15/2004 | US20040138245 Product comprising mikanolide, dihydromikanolide or an analogue thereof combine with another anti-cancer agent for therapeutic use in cancer treatment |
| 07/15/2004 | US20040138235 Adenosine A2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders |
| 07/15/2004 | US20040138234 Histamine receptor antagonists |
| 07/15/2004 | US20040138210 Method of increasing neutrophil production using 2,3-benzodiazepines |
| 07/15/2004 | US20040138189 Moderation of intracellular signals; antitumor agents; drug screening; administering cucurbitacin compound |
| 07/15/2004 | US20040138179 Antifungal formulations |
| 07/15/2004 | US20040138170 Viricides; administering nucleoside with anoth compound such as interferons, interleukin or drug |
| 07/15/2004 | US20040138157 Activation of biosynthesis of Dna; adjust concentration of pyrimidine; using orotic acid, uracil or cytosine |
| 07/15/2004 | US20040138152 adriamycin; chemotherapy; sustained release |
| 07/15/2004 | US20040138145 Application of intestinal biliary acid reuptake inhibitors for the prevention and treatment of alzheimer's disease |
| 07/15/2004 | US20040138140 Combination cancer therapy with a GST-activated anticancer compound and another anticancer therapy |
| 07/15/2004 | US20040138124 immunostimulants used for prophylaxis or prevention diseases related to enzymatic deficiency, to stimulate in vivo hydrolysis of xenobiotics, drugs and toxins, or as antiallergens; metabolic and genetic disorders |
| 07/15/2004 | US20040138121 administering to mammals antitumor agents comprising mixtures of endothelin agonists, anticarcinogenic agents and optionally angiogenesis inhibitors |